PCPG clinical trials at University of California Health

1 research study open to eligible people

ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
open to eligible people ages 18 years and up
This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
at UCLA

Last updated: February 24, 2026